All eight locations for combo trial are now recruiting

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

All eight locations for combo trial are now recruiting

posted on Mar 30, 2017 04:45PM

As originally posted by Fundamentals6 on the Investor Village board, all 8 study locations are now recruiting for the Zenith ZEN-3694/Enzalutamide combo trial.

Hopefully some additional good news will be revealed with the Zenith AACR abstract/presentation.